Via Bid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

but the situation is far fro resolved the case will now go back to the fifth circuit court of appeals, which is considered t be the most conservative appellate court and the country, where it will be argued in front of a three judge panel beginning on may 17th. meanwhile, there are at leas two other cases regarding th legality of mifepristone in a separate case out o washington state, a judg recently ruled that the fd must preserve access to th pill, although the ruling in that case only pertains to the 17 states and the district o columbia that signed on this point of three days ago, genbiopro, the manufacturer of the generi version of mifepristone filed new lawsuit against the fda, i a bid to ensure their produc doesn t get pulled off the mar it at eight yet another strand of complication to the entir issue. because of how contentious confusing and conflicting this situation has become in just a matter of days, it s almos guaranteed we are going to regardless of how the fift circuit

Th countryFifth circuit court of appealsAppellate courtMay 17thSuprem court rulingTh legalityTo washington stateEth pillProduc doesn tEpo columbiaVia bidEntir issueMay 17th hearingFift circuit rules